Primary Prevention
Conditions
Keywords
Immunization, Boot Camp Translation, Adolescent
Brief summary
The overall goal of this project is to implement the Boot Camp Translation process to develop a replicable approach for increasing adolescent vaccine uptake that can be adaptable and feasible to use in rural settings more broadly.
Detailed description
Boot Camp Translation (BCT) is a process to identify strategies that help communities improve health. It is a 6-month, facilitated, iterative community engagement process that brings together relevant stakeholders to develop and implement locally meaningful messages, materials, and strategies for health topics of interest. This is a novel community engagement process that has a proven ability to result in meaningful and impactful strategies to improve compliance with recommended health behaviors in rural communities. The investigators will expand this work by testing BCT on its ability to improve vaccination with all recommend adolescent vaccines (Tdap, MenACWY, HPV, Flu). The investigators will conduct a randomized, controlled trial in which 4 rural communities in Western Colorado will undergo BCT to develop and implement strategies to increase adolescent vaccination. Vaccination rates will be compared to 4 control communities that do not undergo BCT.
Interventions
BEHAVIORALBoot Camp Translation
Communities in the intervention arm will participate in the Boot Camp translation process, where stakeholders will come together to develop and implement locally relevant materials to promote adolescent vaccination.
OTHERControl
No intervention. Communities will continue to behave as usual.
Sponsors
Centers for Disease Control and Prevention
University of Colorado, Denver
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Masking description
The study team data analyst will be provided with blinded data.
Eligibility
Sex/Gender
ALL
Age
11 Years to 17 Years
Healthy volunteers
No
Inclusion criteria
* Must live in one of the designated Colorado communities
Exclusion criteria
* Does not live in one of the designated Colorado communities
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Initiation of HPV vaccination series, 11-12 year olds | Up to 24 months | Percent of 11-12 year olds who have received \>=1 dose of the HPV vaccine by May 31,2021 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Initiation of HPV vaccination series, 13-17 year olds | Up to 24 months | Percent of 13-17 year olds who have received \>=1 dose of the HPV vaccine by May 31,2021 |
| Completion of HPV vaccination series, 13-17 year olds | Up to 24 months | Percent of 13-17 year olds who have completed the HPV vaccine series (2 or 3 doses, depending on age of initiation) by May 31,2021 |
| Receipt of Tdap vaccine, 11-12 year olds | Up to 24 months | Percent of 11-12 year olds who have received Tdap vaccine by May 31,2021 |
| Receipt of Tdap vaccine, 13-17 year olds | Up to 24 months | Percent of 13-17 year olds who have received Tdap vaccine by May 31,2021 |
| Receipt of MCV vaccine, 11-12 year olds | Up to 24 months | Percent of 11-12 year olds who have received \>=1 dose of MCV vaccine by May 31,2021 |
| Receipt of MCV vaccine, 13-17 year olds | Up to 24 months | Percent of 13-17 year olds who have received \>=1 dose of MCV vaccine by May 31,2021 |
| Completion of HPV vaccination series, 11-12 year olds | Up to 24 months | Percent of 11-12 year olds with \>=2 doses of the HPV vaccine by May 31,2021 |
Other
| Measure | Time frame | Description |
|---|---|---|
| Receipt of influenza vaccine | Up to 24 months | Percent of 11-17 year olds who receive the influenza vaccine between Sept 2020 and May 2021 |
Countries
United States
Outcome results
None listed